Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Full Title: Cannabidiol Augmentation of Clozapine in Treatment Resistant Psychosis: a Double-blind, Randomised Controlled Trial

NCT07326124 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT07326124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07326124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Full Title: Cannabidiol Augmentation of Clozapine in Treatment Resistant Psychosis: a Double-blind, Randomised Controlled Trial
Lead sponsor
University of Oxford
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
September 30, 2029
Enrollment
250 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis, treatment resistant psychosis